ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
130 hedge funds and large institutions have $415M invested in Achillion Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 42 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
7% less funds holding
Funds holding: 140 → 130 (-10)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
Holders
130
Holding in Top 10
2
Calls
$4.31M
Puts
$821K
Top Buyers
| 1 | +$41.5M | |
| 2 | +$3.63M | |
| 3 | +$3.32M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.72M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$2.53M |
Top Sellers
| 1 | -$3.38M | |
| 2 | -$3.06M | |
| 3 | -$2.27M | |
| 4 |
Morgan Stanley
New York
|
-$2M |
| 5 |
Citigroup
New York
|
-$1.94M |